CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 52 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-28 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Grant or award | +3,365 | 18,868 | ||
| 2024-03-28 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Grant or award · Stock Options (Right to Buy) | +13,460 | 13,460 | ||
| 2024-03-28 | Gilad Oren President, CEO | Grant or award | +6,725 | 331,495 | ||
| 2024-03-28 | Gilad Oren President, CEO | Grant or award · Stock Options (Right to Buy) | +26,900 | 26,900 | ||
| 2024-03-13 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase | +1,010 | $7.29 | $7K | 15,503 |
| 2024-03-13 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase · Tranche A Warrant | +505 | 505 | ||
| 2024-03-13 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase · Tranche B Warrant | +505 | 505 | ||
| 2024-03-13 | Seizinger Bernd R. Director | Purchase | +6,860 | $7.29 | $50K | 33,685 |
| 2024-03-13 | Seizinger Bernd R. Director | Purchase · Tranche A Warrant | +3,430 | 3,430 | ||
| 2024-03-13 | Seizinger Bernd R. Director | Purchase · Tranche B Warrant | +3,430 | 3,430 | ||
| 2024-03-13 | HENNEMAN JOHN B III Director | Purchase | +6,860 | $7.29 | $50K | 8,139 |
| 2024-03-13 | HENNEMAN JOHN B III Director | Purchase · Tranche A Warrant | +3,430 | 3,430 | ||
| 2024-03-13 | HENNEMAN JOHN B III Director | Purchase · Tranche B Warrant | +3,430 | 3,430 | ||
| 2024-03-13 | Gilad Oren President, CEO | Purchase | +2,000 | $7.29 | $15K | 324,770 |
| 2024-03-13 | Gilad Oren President, CEO | Purchase · Tranche A Warrant | +1,000 | 1,000 | ||
| 2024-03-13 | Gilad Oren President, CEO | Purchase · Tranche B Warrant | +1,000 | 1,000 | ||
| 2023-08-23 | Pamukcu Rifat Director | Grant or award | +500 | 3,356 | ||
| 2023-08-23 | Pamukcu Rifat Director | Grant or award · Stock Options (Right to Buy) | +2,000 | 2,000 | ||
| 2023-08-23 | Grissinger Michael Director | Grant or award | +500 | 799 | ||
| 2023-08-23 | Grissinger Michael Director | Grant or award · Stock Options (Right to Buy) | +2,000 | 2,000 |
Page 5 of 10 · 197 trades